<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vmireaviz</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник медицинского института «РЕАВИЗ». Реабилитация, Врач и Здоровье</journal-title><trans-title-group xml:lang="en"><trans-title>Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2226-762X</issn><issn pub-type="epub">2782-1579</issn><publisher><publisher-name>РЕАВИЗ</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20340/vmi-rvz.2023.5.CLIN.10</article-id><article-id custom-type="elpub" pub-id-type="custom">vmireaviz-786</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Клиническая медицина</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Clinical medicine</subject></subj-group></article-categories><title-group><article-title>Риск венозных тромбоэмболических осложнений у пациентов с сахарным диабетом и COVID-19</article-title><trans-title-group xml:lang="en"><trans-title>Risk of venous thromboembolic complications in patients with diabetes mellitus and COVID-19</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0006-4326-0904</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Абрамов</surname><given-names>Д. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Abramov</surname><given-names>D. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Абрамов Дмитрий Викторович - аспирант, кафедра общей и оперативной хирургии с топографической анатомией и курсом стоматологии,</p><p>ул. Льва Толстого, д. 42, Ульяновск, 432017</p></bio><bio xml:lang="en"><p>42 Lva Tolstogo str., Ulyanovsk, 432017</p></bio><email xlink:type="simple">dmdockap@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5140-7757</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смолькина</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Smol'kina</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Смолькина Антонина Васильевна - д-р мед. наук, профессор, заведующая кафедрой общей и оперативной хирургии с топографической анатомией и курсом стоматологии,</p><p>ул. Льва Толстого, д. 42, Ульяновск, 432017</p></bio><bio xml:lang="en"><p>42 Lva Tolstogo str., Ulyanovsk, 432017</p></bio><email xlink:type="simple">smolant1@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Ульяновский государственный университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ulyanovsk State University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>11</day><month>08</month><year>2023</year></pub-date><volume>13</volume><issue>5</issue><fpage>105</fpage><lpage>108</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Абрамов Д.В., Смолькина А.В., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Абрамов Д.В., Смолькина А.В.</copyright-holder><copyright-holder xml:lang="en">Abramov D.V., Smol'kina A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://vestnik.reaviz.ru/jour/article/view/786">https://vestnik.reaviz.ru/jour/article/view/786</self-uri><abstract><p>В статье дана оценка сопутствующего сахарного диабета, как фактора риска венозных тромбоэмболических осложнений у пациентов с СOVID-19 в условиях стационара. Проанализированы 123 истории болезни пациентов, проходивших стационарное лечение в госпитале для лечения больных с новой коронавирусной инфекцией в первую волну СOVID-19. В результате были получены данные, что сахарный диабет не является независимым фактором риска венозных тромбоэмболических осложнений у пациентов с COVID-19.</p></abstract><trans-abstract xml:lang="en"><p>The article assesses concomitant diabetes mellitus as a risk factor for venous thromboembolic complications in patients with covid-19 in hospital settings. We analyzed 123 case histories of patients hospitalized for new coronavirus infection in the first wave of COVID-19. The results showed that diabetes mellitus was not an independent risk factor for venous thromboembolic complications in patients with COVID-19.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>COVID-19</kwd><kwd>венозные тромбоэмболические осложнения</kwd><kwd>сахарный диабет</kwd><kwd>тромбоэмболия лёгочной артерии</kwd></kwd-group><kwd-group xml:lang="en"><kwd>COVID-19</kwd><kwd>venous thromboembolic complications</kwd><kwd>diabetes mellitus</kwd><kwd>pulmonary embolism</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Васильцева О.Я., Ворожцова И.Н., Крестинин А.В., Карпов Р.С. Сахарный диабет и тромбоэмболия легочной артерии. Комплексные проблемы сердечно-сосудистых заболеваний. 2012;(2):34–38. https://doi.org/10.17802/2306-1278-2012-2-34-38</mixed-citation><mixed-citation xml:lang="en">Vasiltseva O.Y., Vorozhatsova I.N., Kretinin A.V., Karpov R.S. Diabetes and thromboembolism of pulmonary artery. Complex problems of cardiovascular diseases. 2012;(2):34-38. https://doi.org/10.17802/2306-1278-2012-2-34-38</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ahuja N., Bhinder J., Nguyen J., Langan T., O'Brien-Irr M., Montross B. et al. Venous thromboembolism in patients with COVID-19 infection: risk factors, prevention, and management. Seminars in Vascular Surgery. 2021;34(3):101–116. https://doi.org/10.1053/j.semvascsurg.2021.06.002</mixed-citation><mixed-citation xml:lang="en">Natasha Ahuja, Jasmine Bhinder, Jessica Nguyen, Tom Langan, Monica O'Brien-Irr, Brittany Montross, Sikandar Khan, Aditya M Sharma, Linda M. Harris, Venous thromboembolism in patients with COVID-19 infection: risk factors, prevention, and management, Seminars in Vascular Surgery, Volume 34, Issue 3, 2021, Pages 101-116, ISSN 0895-7967, https://doi.org/10.1053/j.semvascsurg.2021.06.002.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Mohammad A.M. Ali, Sarah A. Spinler, COVID-19 and thrombosis: From bench to bedside. Trends in Cardiovascular Medicine. 2021. 31(3):143-160. https://doi.org/10.1016/j.tcm.2020.12.004</mixed-citation><mixed-citation xml:lang="en">Mohammad A.M. Ali, Sarah A. Spinler, COVID-19 and thrombosis: From bench to bedside, Trends in Cardiovascular Medicine, Volume 31, Issue 3, 2021, Pages 143-160, ISSN 1050-1738, https://doi.org/10.1016/j.tcm.2020.12.004.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Andrea T. Obi, Geoffrey D. Barnes, Lena M. Napolitano, Peter K. Henke, Thomas W. Wakefield, Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection. Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2021.9(1):23–35. https://doi.org/10.1016/j.jvsv.2020.08.030</mixed-citation><mixed-citation xml:lang="en">Varghese E, Samuel SM, Liskova A, Kubatka P, Büsselberg D (2021) Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing. PLoS Pathog 17(6): e1009634. https://doi.org/10.1371/journal.ppat.1009634</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Al-kuraishy HM, Al-Gareeb AI, Alblihed M, Guerreiro SG, Cruz-Martins N and Batiha GE-S (2021) COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus. Front. Cardiovasc. Med. 8:644095. https://doi.org/10.3389/fcvm.2021.644095</mixed-citation><mixed-citation xml:lang="en">Xiong X, Chi J, Gao Q. Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta-analysis. Thromb J. 2021 May 19;19(1):32. doi: 10.1186/s12959-021-00284-9. PMID: 34011381; PMCID: PMC8132033.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Varghese E, Samuel SM, Liskova A, Kubatka P, Büsselberg D (2021) Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing. PLoS Pathog. 17(6):e1009634. https://doi.org/10.1371/journal.ppat.1009634</mixed-citation><mixed-citation xml:lang="en">Varghese E, Samuel SM, Liskova A, Kubatka P, Büsselberg D (2021) Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing. PLoS Pathog. 17(6):e1009634. https://doi.org/10.1371/journal.ppat.1009634</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Xiong X, Chi J, Gao Q. Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta-analysis. Thromb J. 2021 May 19;19(1):32. https://doi.org/10.1186/s12959-021-00284-9 PMID: 34011381; PMCID: PMC8132033.</mixed-citation><mixed-citation xml:lang="en">Xiong X, Chi J, Gao Q. Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta-analysis. Thromb J. 2021 May 19;19(1):32. https://doi.org/10.1186/s12959-021-00284-9 PMID: 34011381; PMCID: PMC8132033.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
